NeoGenomics Inc (NEO) stock
NEONasdaqServices-Testing LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/3024% below fair value
$14.82−0.27 (-1.79%)
Close on Nov 20, 2026Market cap $1.92BP/E –Yield –
NeoGenomics free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
NeoGenomics's free cash flow for the twelve months ending Sep 30, 2026 was -$28.58M. For fiscal 2025 it was -$21.78M. The highest annual figure on record is $30.48M in fiscal 2018.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$21.78M | – |
| FY2024 | Dec 31, 2024 | -$34.04M | – |
| FY2023 | Dec 31, 2023 | -$30.71M | – |
| FY2022 | Dec 31, 2022 | -$96.88M | – |
| FY2021 | Dec 31, 2021 | -$90.87M | – |
| FY2020 | Dec 31, 2020 | -$27.64M | -927.4% |
| FY2019 | Dec 31, 2019 | $3.34M | -89.0% |
| FY2018 | Dec 31, 2018 | $30.48M | +601.1% |
| FY2017 | Dec 31, 2017 | $4.35M | -68.8% |
| FY2016 | Dec 31, 2016 | $13.94M | +233.7% |
| FY2015 | Dec 31, 2015 | $4.18M | -26.4% |
| FY2014 | Dec 31, 2014 | $5.68M | +2528.7% |
| FY2013 | Dec 31, 2013 | $216.00K | – |
| FY2012 | Dec 31, 2012 | -$3.11M | – |
| FY2011 | Dec 31, 2011 | -$828.00K | – |
| FY2010 | Dec 31, 2010 | -$2.97M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$20.66M | -3724.2% |
| Q2 FY2026 | Jun 30, 2026 | $11.74M | -16.2% |
| Q1 FY2026 | Mar 31, 2026 | -$13.14M | – |
| Q4 FY2025 | Dec 31, 2025 | -$6.53M | – |
| Q3 FY2025 | Sep 30, 2025 | $570.00K | – |
| Q2 FY2025 | Jun 30, 2025 | $14.01M | +1620.8% |
| Q1 FY2025 | Mar 31, 2025 | -$29.83M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.80M | -116.8% |
| Q3 FY2024 | Sep 30, 2024 | -$1.55M | – |
| Q2 FY2024 | Jun 30, 2024 | $814.00K | – |
| Q1 FY2024 | Mar 31, 2024 | -$31.50M | – |
| Q4 FY2023 | Dec 31, 2023 | $10.73M | – |
| Q3 FY2023 | Sep 30, 2023 | -$9.77M | – |
| Q2 FY2023 | Jun 30, 2023 | -$9.04M | – |
| Q1 FY2023 | Mar 31, 2023 | -$22.62M | – |
| Q4 FY2022 | Dec 31, 2022 | -$8.22M | – |
| Q3 FY2022 | Sep 30, 2022 | -$24.12M | – |
| Q2 FY2022 | Jun 30, 2022 | -$27.29M | – |
| Q1 FY2022 | Mar 31, 2022 | -$37.26M | – |
| Q4 FY2021 | Dec 31, 2021 | -$31.76M | – |
| Q3 FY2021 | Sep 30, 2021 | -$22.74M | – |
| Q2 FY2021 | Jun 30, 2021 | -$22.74M | – |
| Q1 FY2021 | Mar 31, 2021 | -$13.62M | – |
| Q4 FY2020 | Dec 31, 2020 | -$5.52M | – |
| Q3 FY2020 | Sep 30, 2020 | -$7.33M | -164.8% |
| Q2 FY2020 | Jun 30, 2020 | -$3.14M | – |
| Q1 FY2020 | Mar 31, 2020 | -$11.64M | -501.3% |
| Q4 FY2019 | Dec 31, 2019 | -$2.72M | -122.2% |
| Q3 FY2019 | Sep 30, 2019 | $11.32M | +81.6% |
| Q2 FY2019 | Jun 30, 2019 | -$8.16M | -445.4% |
| Q1 FY2019 | Mar 31, 2019 | $2.90M | -69.9% |
| Q4 FY2018 | Dec 31, 2018 | $12.23M | +447.1% |
| Q3 FY2018 | Sep 30, 2018 | $6.23M | +21.4% |
| Q2 FY2018 | Jun 30, 2018 | $2.36M | +41.4% |
| Q1 FY2018 | Mar 31, 2018 | $9.65M | – |
| Q4 FY2017 | Dec 31, 2017 | $2.24M | – |
| Q3 FY2017 | Sep 30, 2017 | $5.13M | – |
| Q2 FY2017 | Jun 30, 2017 | $1.67M | – |
| Q1 FY2017 | Mar 31, 2017 | -$4.69M | – |
| Q4 FY2016 | Dec 31, 2016 | -$2.45M | – |
See a number that looks wrong?